Skip to main content

Advertisement

Table 1 Baseline characteristic of the study population (n = 114)

From: Survival of HIV infected patients on maintenance hemodialysis in Cameroon: a comparative study

Variables HIV-
N = 57
HIV +
N = 57
p
Gender n (%)
 Female 30 (52.6) 30 (52.6)  
 Male 27 (47.4) 27 (47.4) 1
Age (years) Mean ± SDa 46.25 ± 11.41 46.00 ± 11.40 0.909
Matrimonial status n (%)
 Married 42 (73.7) 27 (47.4)  
 Non married 15 (26.3) 30 (52.6) 0.004
Co morbidity n (%)
 History of hypertension 51 (89.5) 35 (61.4) < 0.001
 History of diabetes 15 (26.3) 9 (15.8) 0.168
 Hepatitis B infection 3 (5.3) 4 (7.0) 1
 Hepatitis C infection 8 (14.0) 8 (14.0) 1
Baseline nephropathy
 HIVb 0 (0.0) 29 (50.9)  
 CGNc 19 (33.3) 8 (14.0)  
 Unknown 11 (19.3) 11 (19.3)  
 Hypertension 15 (26.3) 7 (12.3)  
 Diabetes 12 (21.1) 2 (3.5) < 0.001
Vascular access at initiation n (%)
 Temporary CVCd 45 (78.9) 52 (91.2)  
 AVFe 12 (21.1) 5 (8.8) 0.066
Biologic Data    Mean ± SDa
 Haemoglobin 7.86 ± 1.98 7.12 ± 1.70 0.045
 Calcemia 76.59 ± 14.78 73.64 ± 16.78 0.370
 Phosphoremia 71.13 ± 28.84 67.88 ± 35.47 0.639
CD4 count n = 49
 Median (IQRf) 212 (138–455)
 CD4 count<200cells/mm3 n (%) 23 (46.9)
Use of c-ARTg n (%) 44 (77.2)
Drug regimen n (%)(n = 44)  
 1st line 37 (84.1)
 2nd line 6 (13.6)
Hospitalisation rate n (%) 10 (17.5) 12 (21.1) 0.635
  1. aSD Standard deviation, bHIV Human immune deficiency virus, cCGN Chronic glomerulonephritis, dCVC Central venous catheter, eAVF Arterio- venous fistula, fIQR Interquartile range, gc-ART Combined antiretroviral treatment
  2. Values in bold are significant (p < 0.05)